Camlin Fine Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Camlin Fine Sciences has a total shareholder equity of ₹9.4B and total debt of ₹6.9B, which brings its debt-to-equity ratio to 73.5%. Its total assets and total liabilities are ₹20.1B and ₹10.7B respectively. Camlin Fine Sciences's EBIT is ₹927.7M making its interest coverage ratio 1.6. It has cash and short-term investments of ₹1.0B.
Key information
73.5%
Debt to equity ratio
₹6.93b
Debt
Interest coverage ratio | 1.6x |
Cash | ₹1.01b |
Equity | ₹9.42b |
Total liabilities | ₹10.71b |
Total assets | ₹20.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532834's short term assets (₹10.5B) exceed its short term liabilities (₹6.8B).
Long Term Liabilities: 532834's short term assets (₹10.5B) exceed its long term liabilities (₹3.9B).
Debt to Equity History and Analysis
Debt Level: 532834's net debt to equity ratio (62.8%) is considered high.
Reducing Debt: 532834's debt to equity ratio has reduced from 97% to 73.5% over the past 5 years.
Debt Coverage: 532834's debt is not well covered by operating cash flow (11.3%).
Interest Coverage: 532834's interest payments on its debt are not well covered by EBIT (1.6x coverage).